We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+37.99%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$1.36B
AUM Growth
+$289M
Cap. Flow
+$9.14M
Cap. Flow %
0.67%
Top 10 Hldgs %
37.58%
Holding
88
New
23
Increased
16
Reduced
17
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Financials 16.37%
3 Healthcare 10.17%
4 Industrials 9.5%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VG
26
DELISTED
Vonage Holdings Corporation
VG
$20.7M 1.52%
1,604,773
-45,227
-3% -$551K
COOP
27
DELISTED
Mr. Cooper
COOP
$20.6M 1.51%
662,723
+86,764
+15% +$2.22M
KRA
28
DELISTED
Kraton Corporation
KRA
$19.1M 1.4%
688,004
+138,004
+25% +$3.73M
TLND
29
DELISTED
Talend S.A. American Depositary Shares
TLND
$18M 1.32%
+469,526
New +$18.5M
PFSI icon
30
PennyMac Financial
PFSI
$4.02B
$17.6M 1.29%
267,568
-143,617
-35% -$8.54M
AVID
31
DELISTED
Avid Technology Inc
AVID
$15.9M 1.17%
+1,000,000
New +$11.2M
COF icon
32
Capital One
COF
$136B
$15.1M 1.11%
+152,461
New +$13M
SYF icon
33
Synchrony
SYF
$25.8B
$15.1M 1.11%
+433,888
New +$13M
AVYA
34
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$14.8M 1.09%
775,000
-1,068,655
-58% -$19.9M
BDSI
35
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$14.8M 1.09%
3,516,124
-483,876
-12% -$1.86M
EXTR icon
36
Extreme Networks
EXTR
$3.21B
$14.4M 1.06%
+2,092,208
New +$11.2M
ATRS
37
DELISTED
Antares Pharma, Inc.
ATRS
$14.2M 1.05%
+3,570,563
New +$11.6M
CVSA
38
Covista Inc
CVSA
$4.39B
$14.1M 1.04%
+415,030
New +$11.8M
GPRE icon
39
Green Plains
GPRE
$1.06B
$13.9M 1.02%
1,056,330
-336,489
-24% -$5.12M
LMND icon
40
PUT
Lemonade
LMND
$3.99B
$13.3M 0.98%
+108,500
New +$8M
PLYA
41
DELISTED
Playa Hotels & Resorts
PLYA
$13.1M 0.96%
+2,206,348
New +$10.2M
ORBC
42
DELISTED
ORBCOMM, Inc.
ORBC
$12.4M 0.91%
1,673,971
APO icon
43
PUT
Apollo Global Management
APO
$82.4B
$10.8M 0.79%
220,000
LSAK icon
44
Lesaka Technologies
LSAK
$408M
$10.5M 0.77%
2,132,622
RDUS
45
DELISTED
Radius Health, Inc.
RDUS
$10.2M 0.75%
569,062
-658,867
-54% -$9.89M
OMF icon
46
OneMain Financial
OMF
$7.42B
$10.1M 0.74%
+210,000
New +$8.29M
CCO icon
47
Clear Channel Outdoor Holdings
CCO
$1.23B
$7.09M 0.52%
4,297,986
-5,648,096
-57% -$7.1M
MREO
48
Mereo BioPharma
MREO
$47.6M
$6.63M 0.49%
+1,853,417
New +$4.64M
SIOX
49
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.49M 0.48%
2,335,200
+1,875,000
+407% +$5.46M
CVM icon
50
PUT
CEL-SCI Corp
CVM
$25.9M
$5.63M 0.41%
+16,107
New +$6.35M

Similar funds

Rubric Capital Management (New York)'s Q4 2020 Portfolio in Review

As of Q4 2020, Rubric Capital Management (New York) held 88 positions worth $1.36B, up 27% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York)'s Q4 2020 filing shows 23 new, 16 increased, 17 reduced and 24 closed positions. Its largest new stake was Bunge Global: 700,000 shares worth $45.9M. The largest sale was Insmed, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Rubric Capital Management (New York)'s largest Q4 2020 buy was Bunge Global: 700,000 shares worth $45.9M.
  • Rubric Capital Management (New York) added most to Adeia in Q4 2020, an estimated $17.2M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2020 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $19.9M.
  • Rubric Capital Management (New York) fully exited Insmed in Q4 2020, selling an estimated $35.4M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $1.36B portfolio in Q4 2020.
  • Rubric Capital Management (New York) opened 23 new positions and closed 24 in Q4 2020.
  • Rubric Capital Management (New York)'s portfolio value rose 27% quarter-over-quarter to $1.36B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.